ASCO 2017: Neuroblastoma Metastatic to the Central Nervous System: Survival Analyses from the German Childhood Cancer Registry and the Literature (111f56)

Y-mAbs Therapeutics Inc. published this content on May 24, 2017, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 11, 2025 at 18:52 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io